Exchange: NASDAQ·Updated 09:43 AM EDT
EXEL logo

EXEL Exelixis Inc

$58.35
$0.18
(0.31%)
Today
Reported EarningsAug 5
Mkt Cap$14.5B
Vol28,825.00

About EXEL

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
51

Neutral Sentiment

How do you feel about EXEL?

Advertisement|Remove ads.